Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease

Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease

Transplantation of fetal human ventral mesencephalic dopaminergic neurons into the striatum is a promising strategy to compensate for the characteristic dopamine deficit observed in Parkinson’s disease. This therapeutic approach, however, is currently limited by the high number of fetuses needed for...

Full description

Bibliographic Details
Main Authors:	Stefanie eSeiler, Stefano eDi Santo, Hans Rudolf Widmer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-04-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	Parkinson’s disease1 Nogo-A2 cell transplantation3 dopaminergic neurons4 behavior5 rat6.
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fncel.2016.00087/full

Similar Items

Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease
by: Stefanie Seiler, et al.
Published: (2017-05-01)

Behavioral alterations in models of Parkinson's disease
by: Tillerson, Jennifer Layne
Published: (2008)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01)

Roles of stem cells in the treatment of Parkinson's disease
by: Yasaman Ebrahimikia, et al.
Published: (2018-10-01)

Schwann cell expressed Nogo-B modulates axonal branching of adult sensory neurons through the Nogo-B receptor NgBR
by: Christoph eEckharter, et al.
Published: (2015-11-01)

Parkinson’s disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010-11-01)

Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials
by: Se Eun Jang, et al.
Published: (2020-10-01)

Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
by: Sophie V. Precious, et al.
Published: (2020-04-01)

Brain‐derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease
by: E Chang, et al.
Published: (2021-08-01)

Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018)

Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01)

Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson′s disease
by: Stefanie Seiler, et al.
Published: (2015-01-01)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson’s disease.
by: Marta Raquel Carrola Esteves, et al.
Published: (2015-03-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
by: Longping Yao, et al.
Published: (2021-07-01)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
by: Samata, Bumpei
Published: (2017)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

Understanding miRNA Based Gene Regulation in Parkinson’s Disease: An in silico Approach
by: Surya Narayan Rath, et al.
Published: (2020-03-01)

Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson's disease
by: Xiaojuan Han, et al.
Published: (2021-05-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

RISC in PD: The Impact of MicroRNAs in Parkinson’s Disease Cellular and Molecular Pathogenesis
by: Sabrina Mahalia Heman-Ackah, et al.
Published: (2013-11-01)

Neurotrophic factor-based strategies to enhance survival and differentiation of neural progenitor cells toward the dopaminergic phenotype
by: Stefano Di Santo, et al.
Published: (2018-01-01)

Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease
by: Gulay Hacioglu, et al.
Published: (2012-07-01)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission
by: Reza Vajdi-Hokmabad, et al.
Published: (2017-09-01)

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson’s Disease
by: Christelle Lasbleiz, et al.
Published: (2019-02-01)

Glial cells in intracerebral transplantation for Parkinson’s disease
by: Nikola Tomov
Published: (2020-01-01)

Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis
by: Maria Francesca Serapide, et al.
Published: (2020-03-01)

Neurotoxic effects of acrylamide on dopaminergic neurons in primary mesencephalic cell culture
by: Khaled Radad, et al.
Published: (2019-06-01)

Nogo and Nogo receptor: Relevance to schizophrenia?
by: Roman Willi, et al.
Published: (2013-06-01)

Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson's disease
by: Majid Jadidi, et al.
Published: (2016-07-01)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
by: Jie Dong, et al.
Published: (2021-03-01)

Acetaldehyde and parkinsonism: role of CYP450 2E1
by: Francesca eVaglini, et al.
Published: (2013-06-01)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease
by: Julian L. Goggi, et al.
Published: (2020-08-01)

Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model
by: Atsushi Fujita, et al.
Published: (2018-08-01)

The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway
by: Yinquan Fang, et al.
Published: (2018-07-01)

Conditioned Medium Protects Dopaminergic Neurons in Parkinsonian Rats
by: Malihe Nakhaeifard, et al.
Published: (2018-06-01)

A loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by Buffy
by: P. Githure M’Angale, et al.
Published: (2017-06-01)

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
by: Gaia Faustini, et al.
Published: (2017-12-01)

GDNF signaling in subjects with minimal motor deficits and Parkinson's disease
by: Yaping Chu, et al.
Published: (2021-06-01)